We are live on
!
Find out more
RIM
RS Investment Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
3.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.36%
1 Year Est. Return
+3.24%
3 Year Est. Return
+50.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.73B
AUM Growth
-$385M
(-3.8%)
Cap. Flow
-$739M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
14.92%
Holding
438
New
62
Increased
134
Reduced
162
Closed
56
Top Buys
| 1 |
Kirby Corp
KEX
|
+$55M |
| 2 |
Integra LifeSciences
IART
|
+$51.1M |
| 3 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$45.4M |
| 4 |
WBMD
WebMD Health Corp.
WBMD
|
+$43.4M |
| 5 |
Ingevity
NGVT
|
+$39.8M |
Top Sells
| 1 |
Myriad Genetics
MYGN
|
+$81.5M |
| 2 |
Steris
STE
|
+$57.7M |
| 3 |
Red Robin
RRGB
|
+$56.8M |
| 4 |
Dollar General
DG
|
+$52.6M |
| 5 |
Zebra Technologies
ZBRA
|
+$48.1M |
Sector Composition
| 1 | Technology | 17.3% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 14.01% |
| 4 | Consumer Discretionary | 13.08% |
| 5 | Industrials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Gilead Sciences
GILD
$168B
| $2.46M | 0.03% |
29,512
-121,590
| -80% | -$10.8M |
|
302
Cemex
CX
$18.7B
| $2.23M | 0.02% |
375,565
| – | – |
|
303
Banco Santander Chile
BSAC
$15.5B
| $2.22M | 0.02% |
114,701
| – | – |
|
304
Marvell Technology
MRVL
$174B
| $2.05M | 0.02% |
+215,080
| New | +$2.15M |
|
|
EXAR
305
DELISTED
Exar Corporation
EXAR
| $1.96M | 0.02% |
243,440
+68,800
| +39% | +$460K |
|
306
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.89M | 0.02% |
24,250
+3,130
| +15% | +$266K |
|
307
Gen Digital
GEN
$16.2B
| $1.8M | 0.02% |
+87,440
| New | +$1.57M |
|
308
Atlassian
TEAM
$23.8B
| $1.76M | 0.02% |
68,100
+27,810
| +69% | +$659K |
|
309
YPF
YPF
$19.2B
| $1.75M | 0.02% |
91,341
-80,297
| -47% | -$1.6M |
|
310
Southwest Airlines
LUV
$23.7B
| $1.72M | 0.02% |
43,730
-198,560
| -82% | -$8.5M |
|
|
XLNX
311
DELISTED
Xilinx Inc
XLNX
| $1.55M | 0.02% |
+33,560
| New | +$1.53M |
|
|
HIMX
312
Himax Technologies
HIMX
$2.28B
| $1.46M | 0.02% |
176,120
+43,780
| +33% | +$432K |
|
|
ISIL
313
DELISTED
Intersil Corp
ISIL
| $1.44M | 0.01% |
+105,980
| New | +$1.38M |
|
|
YHOO
314
DELISTED
Yahoo Inc
YHOO
| $1.37M | 0.01% |
+36,560
| New | +$1.35M |
|
315
Micron Technology
MU
$1.01T
| $1.32M | 0.01% |
+95,780
| New | +$1.09M |
|
|
OCLR
316
DELISTED
Oclaro Inc.
OCLR
| $1.29M | 0.01% |
+264,450
| New | +$1.31M |
|
|
MXIM
317
DELISTED
Maxim Integrated Products
MXIM
| $1.26M | 0.01% |
+35,200
| New | +$1.29M |
|
318
Johnson & Johnson
JNJ
$608B
| $1.21M | 0.01% |
10,007
+1,610
| +19% | +$183K |
|
|
P
319
DELISTED
Pandora Media Inc
P
| $1.2M | 0.01% |
96,650
| – | – |
|
320
HubSpot
HUBS
$11.3B
| $1.18M | 0.01% |
+27,150
| New | +$1.23M |
|
321
ServiceNow
NOW
$108B
| $1.08M | 0.01% |
+81,350
| New | +$1.13M |
|
322
Colgate-Palmolive
CL
$74.3B
| $1.06M | 0.01% |
14,479
| – | – |
|
323
Illumina
ILMN
$28.1B
| $1.06M | 0.01% |
7,751
-2,365
| -23% | -$336K |
|
|
RAX
324
DELISTED
Rackspace Hosting Inc
RAX
| $1.01M | 0.01% |
48,260
-13,640
| -22% | -$319K |
|
325
SPDR Gold Trust
GLD
$130B
| $991K | 0.01% |
7,832
+2,692
| +52% | +$324K |
|
Similar funds
SG
KGI
VAM
FBNAT
CPS
LH
CPM
VFS
RS Investment Management's Q2 2016 Portfolio in Review
As of Q2 2016, RS Investment Management held 438 positions worth $9.73B, down 3.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RS Investment Management withdrew a net $739M in Q2 2016, closing 56 positions and reducing 162 holdings. Its most notable exit was Myriad Genetics, an estimated $81.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, RS Investment Management opened a new position in Kirby Corp worth $52.4M.
- RS Investment Management's largest Q2 2016 buy was Kirby Corp: 839,753 shares worth $52.4M.
- RS Investment Management added most to Allergan plc in Q2 2016, an estimated $36.7M increase.
- RS Investment Management's biggest Q2 2016 reduction was Steris, cutting an estimated $57.7M.
- RS Investment Management fully exited Myriad Genetics in Q2 2016, selling an estimated $81.5M.
- RS Investment Management's ten largest holdings make up 15% of its $9.73B portfolio in Q2 2016.
- RS Investment Management opened 62 new positions and closed 56 in Q2 2016.
- RS Investment Management's portfolio value fell 3.8% quarter-over-quarter to $9.73B.
Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.